doi:10.3969/j.issn.1004-583X.2026.09.011

Abstract

CLC Number:

R563.1

Add to citation manager EndNote|Ris|BibTeX

URL: https://www.lchc.cn/EN/10.3969/j.issn.1004-583X.2026.09.011

https://www.lchc.cn/EN/Y2026/V41/I9/848

References 36

[1]	国家卫生健康委员会,国家中医药局. 儿童肺炎支原体肺炎诊疗指南(2025 年版)[Z]. 国卫办医政函〔2025〕361 号, 2025.
[2]	张蔷. 安徽省儿童医院儿童肺炎支原体肺炎流行病学及临床特点[D]. 合肥: 安徽医科大学, 2024.doi:2024.10.26921/d.cnki.ganyu.2024.000229.
[3]	喻文清. 儿童重症肺炎支原体肺炎的临床及影像特点分析[D]. 重庆: 重庆医科大学, 2023.doi:2023.10.27674/d.cnki.gcyku.2023.002197.
[4]	Wang H, Xu WH, Liu JR, et al. Clinical phenotyping of severe Mycoplasma pneumoniae pneumonia in children[J]. Chin J Pediatr, 2024, 62(7): 669-675. doi:10.3760/cma.j.cn112140-20231227-00466. pmid: 38955686
[5]	Mu SY, Zou YX, Guo YS, et al. Clinical characteristics and predictive factors for plastic bronchitis in children with severe Mycoplasma pneumoniae pneumonia[J]. Chin J Pediatr, 2024, 62(9): 861-866.doi:10.3760/cma.j.cn112140-20240417-00272. pmid: 39192444
[6]	Zhou HH, Qian KL. Comparison of the systemic inflammatory response index and the systemic immune-inflammatory index in pediatric community-acquired pneumonia caused by respiratory syncytial virus and Mycoplasma pneumoniae[J]. Front Pediatr, 2025, 13: 1694856. doi:10.3389/fped.2025.1694856.
[7]	Jiang C, Bao S, Shen W, et al. Predictive value of immune-related parameters in severe Mycoplasma pneumoniae pneumonia in children[J]. Transl Pediatr, 2024, 13(9): 1521-1528. doi:10.21037/tp-24-172.
[8]	Zhang F. Immunopathogenesis, molecular phenotyping, and host-directed interventions for severe pediatric Mycoplasma pneumoniae pneumonia in the post-pandemic era[EB/OL]. Front Cell Infect Microbiol, 2026, 16: 1833802. [2026-08-07]. doi: 10.3389/fcimb.2026.1833802.
[9]	单新洁, 乌兰, 黄倩文, 等. 2023年冬季儿童支原体肺炎患者促炎和抗炎细胞因子表达水平及临床意义[J]. 当代医药论丛, 2025, 23(26): 5-7.
[10]	刘洋, 崔玉霞. 儿童肺炎支原体肺炎Th1/Th2细胞因子变化特征及其相关免疫机制的研究进展[J]. 贵州医药, 2023, 47(4): 520-521.
[11]	Liu J, Bao B, Zhang T, et al. Comparative analysis of the clinical characteristics of severe Mycoplasma pneumoniae pneumonia and severe bacterial pneumonia in children[J]. BMC Pediatrics, 2025, 25(1): 439. doi:10.1186/s12887-025-05804-4.
[12]	Zhou X, Zhang B, Li Y, et al. Association between gustave roussy immune score and delay in discharge among children and adolescents with Mycoplasma pneumoniae pneumonia: A retrospective cohort study[J]. Front Pediatr, 2025, 13: 1564217. doi:10.3389/fped.2025.1564217.
[13]	Shen X, Jin Z, Chen X, et al. Single-cell transcriptome atlas revealed bronchoalveolar immune features related to disease severity in pediatric Mycoplasma pneumoniae pneumonia[J]. MedComm(2020), 2024, 5(10): e748. doi:10.1002/mco2.748.
[14]	Sun Y, Tong L, Lin M, et al. Age-specific cytokine profiling in children with Mycoplasma pneumoniae infections in post-COVID-19 era: A retrospective study[J]. J Inflamm Res, 2025, 18: 17731-17746. doi:10.2147/JIR.S558898.
[15]	Liu F, Wang Q, Cheng Q, et al. Immune activation and mucin dysregulation in pediatric refractory Mycoplasma pneumoniae pneumonia with mucus plugs[J]. Front Cell Infect Microbiol, 2026, 15: 1706340. doi:10.3389/fcimb.2025.1706340.
[16]	Song H, Fan J, Wang H, et al. The predictive accuracy of systemic immune-inflammation index and lymphocyte-to-monocyte ratio for extrapulmonary complications in pediatric Mycoplasma pneumoniae pneumonia: A retrospective cohort study[J]. Transl Pediatr, 2025, 14(12): 3387-3397.doi: 10.21037/TP-2025-488.
[17]	Fan GZ, Zhu YH, Hu LX, et al. Predictive value of traditional and novel composite inflammatory indicators for severe and refractory Mycoplasma pneumoniae pneumonia in children[J]. J Inflamm Res, 2025, 18: 16981-16990. doi: 10.2147/JIR.S561489.
[18]	陈梦雪, 李京阳, 杨芬, 等. 儿童大环内酯类耐药重症肺炎支原体肺炎的临床特征及危险因素分析[J]. 临床儿科杂志, 2024, 42(3): 187-192.doi:10.12372/jcp.2024.24e0026.
[19]	曾玲, 谢乐云, 虞仁和, 等. 基于年龄分组的儿童肺炎支原体肺炎临床特征及发生大叶性肺炎的高危因素分析[J/OL]. 中国全科医学, 1-8[2026-08-14]. https://link.cnki.net/urlid/13.1222.r.20250707.0836.002.
[20]	Sa RN, Wang AQ, Gao YH, et al. Efficacy of bronchoalveolar lavage combined with prone positioning in children with Mycoplasma pneumoniae pneumonia and atelectasis: A prospective randomized controlled study[J]. Chin J Pediatr, 2024, 26(1): 31-36.doi:10.7499/j.issn.1008-8830.2308013.
[21]	许海乾, 江祎桢, 蔡梦云, 等. 支气管镜肺泡灌洗治疗儿童肺炎支原体肺炎并肺实变200例的疗效[J]. 延边大学医学学报, 2025, 48(11): 32-35.doi:32-35.10.16068/j.1000-1824.2025.11.009.
[22]	林秋章. 支气管镜肺泡灌洗术治疗儿童支原体肺炎合并肺实变的效果[J]. 中外医药研究, 2025, 4(6): 27-29 doi:10.3969/j.issn.2096-2665.2023.19.010.
[23]	辛叶. 行支气管肺泡灌洗术的儿童重症肺炎支原体肺炎的临床特征分析及预测模型构建[D]. 锦州: 锦州医科大学, 2025.doi:10.27812/d.cnki.glnyx.2025.000865.
[24]	Liang M, Zhang H, Li Y, et al. A prediction model for bronchoalveolar lavage in children with Mycoplasma pneumoniae pneumonia and consolidation[J]. Sci Rep, 2026, 16(1): 3152. doi:10.1038/s41598-025-32941-8.
[25]	崔慧贤, 葛宾, 赵静维, 等. 软式支气管镜肺泡灌洗的时机选择对儿童重症肺炎支原体肺炎的治疗效果、血气指标及炎症因子水平的影响[J]. 检验医学与临床, 2025, 22(9): 1262-1266.doi:10.3969/j.issn.1672-9455.2025.09.021.
[26]	李瑞. 纤维支气管镜肺泡灌洗术治疗儿童支原体肺炎的效果[J]. 系统医学, 2025, 10(11): 149-152. doi:10.19368/j.cnki.2096-1782.2025.11.149.
[27]	蒋美红, 袁琛. 纤维支气管镜肺泡灌洗治疗儿童难治性肺炎支原体肺炎的临床观察[J]. 中华全科医学, 2025, 23(2): 269-272. doi:10.16766/j.cnki.issn.1674-4152.003883.
[28]	黄龙, 朱明, 曾旭华, 等. 支气管镜肺泡灌洗术在儿童重症肺炎支原体肺炎中的应用[J]. 青岛医药卫生, 2025, 57(3): 189-192. doi:10.3969/j.issn.1006-5571.2025.03.007.
[29]	Gao J, Wu R, Zhang YJ, et al. Quantitative evaluation of bronchoalveolar lavage for the treatment of severe Mycoplasma pneumoniae pneumonia in children-A new complementary index: Bronchial insufflation sign score[J]. J Clin Ultrasound, 2024, 52(6): 667-674.doi:10.1002/JCU.23678.
[30]	Yue H, Sheng Q, Wang X, et al. A comparison of diagnostic and therapeutic approaches for Mycoplasma pneumoniae pneumonia in children and adults, during the post-COVID-19 pandemic era[J]. Eur J Clin Microbiol Infect Dis, 2025, 44(7): 1677-1694. doi:10.1007/S10096-025-05142-4.
[31]	Li LP, Fu MH, Liu K, et al. Effect of bronchofiberscopic lavage with acetylcysteine instillation on refractory Mycoplasma pneumoniae pneumonia in children: A retrospective clinical observation[J]. Ital J Pediatr, 2025, 51(1): 62. doi: 10.1186/s13052-025-01879-y.
[32]	Zhang Z, Sun Y, Wang J, et al. Interventional therapy for a case of Mycoplasma pneumoniae pneumonia complicated by upper extremity arterial embolism in a child: A case report[J]. Thromb J, 2025, 23(1): 60. doi:10.1186/s12959-025-00748-2.
[33]	任雪, 王丽杰. 不同年龄儿童重症及危重症肺炎支原体肺炎临床特征分析[J]. 中国临床新医学, 2025, 18(8): 848-853. doi:10.3969/j.issn.1674-3806. 2025.08.04.
[34]	Chen L, Yin J, Liu X, et al. Thromboembolic complications of Mycoplasma pneumoniae pneumonia in children[J]. Clin Respir J, 2023, 17(3): 187-196. doi:10.1111/CRJ.13584.
[35]	Yu Y, Jin X, Zhang X, et al. Pulmonary thrombotic complication of Mycoplasma pneumoniae pneumonia in Chinese children: Clinical feature and risk factor analysis[J]. Pediatr Infect Dis J, 2024, 43(6): doi:505-510. doi: 10.1097/INF.0000000000004287.
[36]	时春华, 顾婷. 阶段式肺康复锻炼对儿童支原体肺炎的干预效果[J]. 名医, 2024, (5): 63-65.doi:10.20255/j.cnki.issn1674-9561.2024.05.022.

RichHTML

PDF (PC)

Knowledge

Abstract

Cite this article

share this article

References 36

Related Articles 15

Recommended Articles

Metrics

Comments

[1]	Chen Zhi, Ding Pengyan, Hao Guizhen, Li Yulong, Niu Shiliang, Shen Limin, Liu Chunxia. Effect of mechanical insufflation-exsufflation technique on the prevention and treatment of pulmonary infection in ICU patients with weak or absent cough reflex [J]. Clinical Focus, 2026, 41(8): 695-699.
[2]	Qiu Xiaoyu, Yang Huiyang, Luan Xiaofei. Clinical efficacy of bronchoscopic lavage combined with methylprednisolone sodium succinate in the treatment of severe pneumonia in children [J]. Clinical Focus, 2026, 41(7): 614-618.
[3]	Shi Jungang, Wei Caihong, Cui Yonghui, Guo Dan, Li Jiayue, Cai Hourong. A case of diffuse pulmonary ossification diagnosed by cryobiopsy [J]. Clinical Focus, 2026, 41(6): 546-550.
[4]	Xia Qi, Luo Ping, Liu Mingfeng, Lin Jiamin, Zhang Weichao. Performance of an early quantitative swallowing assessment-based decision tree for predicting stroke-associated pneumonia [J]. Clinical Focus, 2026, 41(2): 108-115.
[5]	. [J]. Clinical Focus, 2025, 40(6): 553-557.
[6]	Wu Wanfeng, Wang Yunyun, Yang Daokun. Comparative study on the clinical efficacy of different antiviral drugs in the treatment of COVID-19 [J]. Clinical Focus, 2025, 40(2): 147-152.
[7]	Li Dengfeng, Huang Jiahu, Li Tingjun, Lv Yong, Jin Zhenzhen, Lian Shaofeng. Construction of a prediction model for refractory mycoplasma pneumoniae pneumonia in children based on lung ultrasound score [J]. Clinical Focus, 2025, 40(2): 153-157.
[8]	. [J]. Clinical Focus, 2025, 40(2): 185-188.
[9]	Yang Xiaolin, Yang Yan. Clinical characteristics of children with Mycoplasma pneumoniae infection complicated with asthmatic bronchopneumonia [J]. Clinical Focus, 2024, 39(9): 808-811.
[10]	. [J]. Clinical Focus, 2024, 39(7): 668-672.
[11]	Yu Jingyi, Si Yuanguo, Lan Cuixia, Xing Jiaxuan. Safety and efficacy of rivaroxaban in the treatment of discharged COVID-19 patients: A meta-analysis [J]. Clinical Focus, 2024, 39(6): 485-493.
[12]	Yan Yaru, Zhao Haotian, Zhang Jiesi, Wang Xiaona, Zhao Heling. Ultrasound evaluation of speckle tracking imaging on right ventricular function and right ventricular pulmonary artery coupling in severe pneumonia underwent mechanical ventilation versus common pneumonia [J]. Clinical Focus, 2024, 39(6): 531-536.
[13]	Yun Xiaoxiao, Li Shufen, Sun Fang. Clinical features of adenovirus pneumonia in immunocompetent adults: A meta-analysis [J]. Clinical Focus, 2024, 39(4): 293-303.
[14]	Zhi Bingdi, Liu Ying, Liu Ying, Zhang Fubo, Li Junfeng. SARS-CoV-2 infection combined with Listeria meningitis: A case report and literature review [J]. Clinical Focus, 2024, 39(4): 347-351.
[15]	Zhang Xia, Tang Yan, Liu Wenli, Liu Juan. Value of lung ultrasound in the assessment of community-acquired pneumonia in infants aged 1-3 months [J]. Clinical Focus, 2024, 39(3): 234-238.